These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31761925)

  • 1. In vitro leishmanicidal activity of antimicrobial peptide KDEL against Leishmania tarentolae.
    Cao L; Jiang W; Cao S; Zhao P; Liu J; Dong H; Guo Y; Liu Q; Gong P
    Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1286-1292. PubMed ID: 31761925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Anti-Microbial Peptide from Pseudomonas, REDLK Induced Growth Inhibition of Leishmania tarentolae Promastigote In Vitro.
    Yu Y; Zhao P; Cao L; Gong P; Yuan S; Yao X; Guo Y; Dong H; Jiang W
    Korean J Parasitol; 2020 Apr; 58(2):173-179. PubMed ID: 32418386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halictine-2 antimicrobial peptide shows promising anti-parasitic activity against Leishmania spp.
    Pitale DM; Kaur G; Baghel M; Kaur KJ; Shaha C
    Exp Parasitol; 2020 Nov; 218():107987. PubMed ID: 32891601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.
    Erfe MC; David CV; Huang C; Lu V; Maretti-Mira AC; Haskell J; Bruhn KW; Yeaman MR; Craft N
    Antimicrob Agents Chemother; 2012 Feb; 56(2):658-65. PubMed ID: 22123683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival.
    Lynn MA; Kindrachuk J; Marr AK; Jenssen H; Panté N; Elliott MR; Napper S; Hancock RE; McMaster WR
    PLoS Negl Trop Dis; 2011; 5(5):e1141. PubMed ID: 21655347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biogenic silver nanoparticles inducing Leishmania amazonensis promastigote and amastigote death in vitro.
    Fanti JR; Tomiotto-Pellissier F; Miranda-Sapla MM; Cataneo AHD; Andrade CGTJ; Panis C; Rodrigues JHDS; Wowk PF; Kuczera D; Costa IN; Nakamura CV; Nakazato G; Durán N; Pavanelli WR; Conchon-Costa I
    Acta Trop; 2018 Feb; 178():46-54. PubMed ID: 29111137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies.
    Bolhassani A; Taheri T; Taslimi Y; Zamanilui S; Zahedifard F; Seyed N; Torkashvand F; Vaziri B; Rafati S
    Exp Parasitol; 2011 Mar; 127(3):637-45. PubMed ID: 21187086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice.
    Abdossamadi Z; Taheri T; Seyed N; Montakhab-Yeganeh H; Zahedifard F; Taslimi Y; Habibzadeh S; Gholami E; Gharibzadeh S; Rafati S
    Immunotherapy; 2017 Oct; 9(13):1089-1102. PubMed ID: 29032739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
    Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
    ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the leishmanicidal activity of antimicrobial peptides.
    Luque-Ortega JR; Rivas L
    Methods Mol Biol; 2010; 618():393-420. PubMed ID: 20094878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for antimicrobial peptide-based immunotherapy approaches in Leishmania control.
    Zahedifard F; Rafati S
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):461-469. PubMed ID: 29889579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cruzioseptins, antibacterial peptides from Cruziohyla calcarifer skin, as promising leishmanicidal agents.
    Mendes B; Proaño-Bolaños C; Gadelha FR; Almeida JR; Miguel DC
    Pathog Dis; 2020 Sep; 78(6):. PubMed ID: 32926094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study.
    Khalili S; Ebrahimzade E; Mohebali M; Shayan P; Mohammadi-Yeganeh S; Moosazadeh Moghaddam M; Elikaee S; Akhoundi B; Sharifi-Yazdi MK
    Exp Parasitol; 2019 Jan; 196():48-54. PubMed ID: 30496731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grandiflorenic acid promotes death of promastigotes via apoptosis-like mechanism and affects amastigotes by increasing total iron bound capacity.
    Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Miranda-Sapla MM; Assolini JP; Carloto ACM; de Carvalho PGC; Cardoso ILA; Simão ANC; Arakawa NS; Costa IN; Conchon-Costa I; Pavanelli WR
    Phytomedicine; 2018 Jul; 46():11-20. PubMed ID: 30097110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modes of action of Leishmanicidal antimicrobial peptides.
    Marr AK; McGwire BS; McMaster WR
    Future Microbiol; 2012 Sep; 7(9):1047-59. PubMed ID: 22953706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.
    Pérez-Cordero JJ; Lozano JM; Cortés J; Delgado G
    Peptides; 2011 Apr; 32(4):683-90. PubMed ID: 21262294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo.
    Chouhan G; Islamuddin M; Want MY; Abdin MZ; Ozbak HA; Hemeg HA; Sahal D; Afrin F
    Parasit Vectors; 2015 Mar; 8():183. PubMed ID: 25884649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa.
    Chadbourne FL; Raleigh C; Ali HZ; Denny PW; Cobb SL
    J Pept Sci; 2011 Nov; 17(11):751-5. PubMed ID: 21805542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entomopathogenic bacteria Photorhabdus luminescens as drug source against Leishmania amazonensis.
    Antonello AM; Sartori T; Folmer Correa AP; Brandelli A; Heermann R; Rodrigues Júnior LC; Peres A; Romão PRT; Da Silva OS
    Parasitology; 2018 Jul; 145(8):1065-1074. PubMed ID: 29157317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-leishmanial efficacy of potato tuber extract (PTEx): leishmanial serine protease(s) as putative target.
    Paik D; Das P; De T; Chakraborti T
    Exp Parasitol; 2014 Nov; 146():11-9. PubMed ID: 25128800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.